SCHEMBL14722010

SCHEMBL14722010

CC(=C1CCN(C2CCC2)CC1)c1ccc(-c2nc(C)no2)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.41
ACHE P22303 1/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
P2RX3 P56373 2/20 0.39
OPRK1 P41145 1/20 0.39
TP53 P04637 2/20 0.39
MAPT P10636 1/20 0.39
POLB P06746 1/20 0.37
KCNH2 Q12809 2/20 0.37
S1PR1 P21453 2/20 0.36
S1PR5 Q9H228 1/20 0.36
USP7 Q93009 1/20 0.36
ACKR3 P25106 1/20 0.35
HTT P42858 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
CHRM2 P08172 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14730970 0.78 ACHE (0.42) GPR119ACHELMNATHRBOPRK1
SCHEMBL1169846 0.77 L3MBTL3 (0.53) GPR119HRH3
Hydrochloric Acid SCHEMBL1169593 0.76 L3MBTL3 (0.52) GPR119HRH3
SCHEMBL5664906 0.75 HRH3 (0.45) ACHEOPRK1KCNH2HRH3
SCHEMBL1171392 0.73 ACHE (0.37) GPR119ACHELMNATHRBP2RX3
SCHEMBL5210559 0.72 S1PR1 (0.43) GPR119ACHELMNATHRBP2RX3
SCHEMBL600062 0.72 L3MBTL3 (0.44) GPR119HRH3
SCHEMBL14720722 0.71 KDM2B (0.43) OPRK1HRH3CHRM2
SCHEMBL1172018 0.71 ACHE (0.37) GPR119ACHELMNATHRBP2RX3
SCHEMBL14720484 0.69 ALDH1A1 (0.58) OPRK1MAPTPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed